Adicet Bio, Inc.’s $137.5 Million Rights Offering

Goodwin Procter LLP advised Adicet Bio, Inc. on the deal.Adicet Bio, Inc. (Nasdaq: ACET) announced its underwritten public offering of 10,575,513 shares of its common stock, including…

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here
Martina Bellini

Author: Martina Bellini

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here